Hideki Shima News Today

The €330m Astellas facility in Kerry is set to be operational within four years according to the company who on Monday turned the sod on the building of a state-of-the-art facility at the Kerry Technology Park.

Japanese ambassador to Ireland Norio Maruyama was in Kerry for a sod-turning ceremony at Kerry Technology Park for the new €330m Astellas pharmaceutical plant

Hideki Shima says the company identified Tralee as the location for the new facility due to the talent pool.

Kerry pharmaceutical company Astellas has applied for planning for its proposed production facility in Tralee.

Astellas Pharma, a pharmaceutical company, plans to submit a planning application for the construction of a brand-new, €330 million state-of-the-art facility...

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced its intention to submit a planning application...

There is positive news for Tralee on the economic and jobs front following the announcement that Astellas Pharma Ireland is to apply for planning permission for a state-of-the-art €330 million facility at the Kerry Technology Park in Tralee.

Astellas Pharma has announced that it is to invest more than €330 million in a new state of the art facility in Tralee.The Tokyo based company already has a fac...

Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) has announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330m in Tralee, Co. Kerry. This investment by Astellas in Ireland will expand our capacity and capabilities for aseptic drug products, reinforce stable production